IMPDH2-IN-4 (compound 2d), a Mycophenolic acid (HY-B0421) analogue, is a selective IMPDH2 inhibitor with a Ki of 1.8 µM. IMPDH2-IN-4 exhibits good cytotoxic activity against osteosarcoma cancer cell lines. IMPDH2-IN-4 possesses a high affinity for VEGFR-2, CDK2, and IMPDH[1].
Molecular Weight:
578.73
Formula:
C35H34O6Si
Target:
CDK,VEGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted